by Pfizer Inc.
This resource provides personalized support for patients prescribed BRAFTOVI® (encorafenib) for colorectal cancer, melanoma, or non-small cell lung cancer (NSCLC). Patients can explore financial assistance options, co-pay savings, insurance support, treatment resources, and guidance to help navigate their prescribed medication.
